8b61426a2e895462ac5e6a0fce9d93d1b0fae2b5

Nexortest Technologies | Your Gateway to Global Market Entry

Morocco AMMPS Medical Device Registration & Regulatory Consultant

Navigate Morocco's AMMPS regulatory framework with confidence. NexorTest Technologies provides end-to-end medical device registration consulting — from device classification and dossier preparation through AMMPS submission and import permit management — for Class I through Class III devices, IVDs, and SaMD.

Free Morocco Assessment

Get a personalised regulatory roadmap in 24 hours

No obligation. Response within 24 hours.
AMMPS Classification Pathways

EU MDD-Aligned Device Classes Under Loi 84-12

Morocco classifies medical devices using an EU MDD-aligned system. Your device class determines the registration pathway, documentation requirements, and AMMPS review timeline.

Class I — Low Risk
Class I Devices

Lowest-risk devices including non-sterile bandages, tongue depressors, examination gloves, and non-invasive reusable instruments. Follows a simplified notification pathway with AMMPS.

How does the Class I process work in Morocco?

Class I devices follow a simplified notification pathway. Manufacturers submit a notification dossier with CE certificate (if applicable), Free Sale Certificate from the country of origin, Declaration of Conformity, and basic technical documentation. AMMPS reviews the administrative completeness and issues a registration certificate without full technical evaluation.

Class IIa — Medium Risk
Class IIa Devices

Medium-risk devices such as surgical instruments, hearing aids, diagnostic ultrasound equipment, and powered surgical tools. Requires standard AMMPS review of the technical dossier.

What documentation is needed for Class IIa?

Class IIa devices require a complete technical dossier in French including product specifications, risk management file (ISO 14971), performance data, CE certificate from a Notified Body, ISO 13485 QMS certificate, and labeling in French and Arabic. AMMPS conducts a standard technical review within the 120-day statutory period.

Class IIb — Medium-High Risk
Class IIb Devices

Medium-high risk devices including ventilators, infusion pumps, blood bags, and haemodialysis equipment. Requires full AMMPS review with clinical evaluation documentation.

Is clinical data mandatory for Class IIb?

Yes. Class IIb devices require a clinical evaluation report per Article 15 of Loi 84-12, demonstrating safety and performance through clinical literature, clinical investigation data, or equivalence assessment. AMMPS conducts a full technical and clinical review, and the advisory commission may request additional evidence before granting approval.

Class III — Highest Risk
Class III Devices

Class III Devices

What makes Class III review more stringent?

Class III devices undergo the most rigorous AMMPS evaluation, including comprehensive clinical evidence review, detailed risk-benefit analysis, and mandatory advisory commission assessment. The dossier must include extensive clinical investigation data, long-term safety evidence, and post-market surveillance commitments. Registration certificates for Class III devices are valid for 5 years with enhanced post-market monitoring requirements.

Our AMMPS Services

Comprehensive AMMPS Registration Services

From initial classification through post-market surveillance, NexorTest manages every aspect of your Morocco regulatory journey.

AMMPS Device Registration

End-to-end registration under Loi 84-12 and Décret 2-14-607. Complete dossier preparation, AMMPS submission management, advisory commission review facilitation, and registration certificate acquisition for all device classes from Class I through Class III.

Local Authorized Representative (ALR)

Appointment and management of a Moroccan Local Authorized Representative with a qualified pharmacist or biomedical engineer on staff, compliant warehouse facilities, and established recall procedures as mandated by Décret 2-14-607.

CE Marking Recognition

Leveraging CE marking acceptance in Morocco's regulatory framework. Preparation and verification of EC certificates, Declarations of Conformity, and all supporting documentation accepted by AMMPS as evidence of conformity for streamlined registration.

Technical File Preparation (French)

Complete technical dossier preparation in French including product specifications, manufacturing process documentation, materials and components lists, risk management file (ISO 14971), clinical evaluation report, and post-market surveillance plan per AMMPS requirements.

ISO 13485 QMS Implementation

Full Quality Management System implementation required for AMMPS dossier submission. Includes gap analysis against ISO 13485:2016, documentation development, process optimization, internal audit support, and coordination with certification bodies.

Clinical Evaluation Reports

Clinical evaluation per Article 15 of Loi 84-12. Literature-based clinical evaluation, clinical investigation support, equivalence assessment for predicate devices, and compilation of clinical evidence packages meeting AMMPS advisory commission requirements.

IVD Registration Morocco

Specialized In Vitro Diagnostic device registration with local technical evaluation. Extended timeline management for IVD categories (up to 12 months), IVD-specific documentation preparation, analytical performance data compilation, and AMMPS IVD submission support.

Import Permit Management

Per-shipment import permit processing with approximately 2-week turnaround per permit. Annual import planning, customs documentation preparation, PortNet platform submissions, warehouse coordination, and ongoing logistics compliance management.

Post-Market Surveillance & Matériovigilance

Comprehensive PMS system setup, adverse event reporting to AMMPS, field safety corrective action management, periodic safety update reports, and ongoing compliance monitoring to maintain your 5-year registration certificate in good standing.

Why NexorTest

Your TrustedMorocco AMMPS Specialist

We combine deep local regulatory expertise with global experience to deliver faster, more predictable AMMPS registrations.

French & Arabic Regulatory Expertise

Bilingual team fluent in Morocco's official regulatory languages. All dossier preparation, AMMPS correspondence, labeling review, and documentation managed in French and Arabic to meet statutory language requirements.

Design + Testing + Certification Under One Roof

Integrated services covering product design review, safety and performance testing at our own accredited labs, and complete regulatory certification — eliminating multi-vendor complexity and accelerating your path to market.

AMMPS Submission Specialists

Direct experience with AMMPS advisory commission processes, PortNet electronic submissions, per-model registration requirements, and the transition from the former DMP to the new AMMPS framework under Loi 10-22.

Multi-Region Regulatory Expertise

Simultaneous registrations across AMMPS, EU MDR, US FDA, CDSCO, SFDA, and 40+ markets worldwide. One partner for global market access from a single integrated regulatory program.

Transparent Pricing & Fixed-Fee Packages

No hidden costs or hourly billing surprises. Our fixed-fee packages cover the complete scope from regulatory strategy through registration certificate issuance, with clear milestones and deliverables at every stage.

First Submission Acceptance
0 %
Countries Served
0 +
Faster Than Industry Average
0 %
Our Process

Six Steps to Your AMMPS Registration

A proven, structured approach that minimizes review queries and accelerates your path to the Moroccan medical device market.

1
Device Classification & Regulatory Strategy

We classify your device under Morocco’s EU MDD-aligned system (Class I, Im, Is, IIa, IIb, or III) and develop a tailored regulatory strategy including applicable standards, documentation requirements, and the optimal submission pathway under Loi 84-12.

2
Local Representative Establishment

We appoint an AMMPS-approved Local Authorized Representative (ALR) in Morocco with a qualified pharmacist or biomedical engineer on staff, compliant warehouse and storage facilities, and established recall and field safety corrective action procedures.

3
Documentation & Technical File (French)

Our team prepares the complete administrative and technical dossier in French, including product specifications, manufacturing process details, risk management file, clinical evaluation report, CE certificates, and post-market surveillance plan.

4
AMMPS Submission via PortNet

We submit the completed registration dossier electronically through the interconnected PortNet platform with all supporting documents, administrative forms, applicable government fees, and the required CE certificates and Free Sale Certificate.

5
AMMPS Review & Advisory Commission

We navigate the AMMPS review process within the statutory 120-day review period, respond to technical queries promptly, provide additional information as requested, and facilitate advisory commission approval for higher-risk device categories.

6
Registration Certificate & Import Permits

Upon approval, we obtain your 5-year registration certificate and establish ongoing per-shipment import permit processing through the PortNet platform, including annual import planning, customs documentation, and logistics coordination.

Industries We Serve

AMMPS Registration Across All Device Sectors

NexorTest supports medical device manufacturers across every therapeutic area and technology vertical entering the Moroccan market.

Frequently Asked Questions

Morocco AMMPS Registration FAQ

Expert answers to the most common questions about medical device registration with AMMPS Morocco.

AMMPS medical device registration is the mandatory regulatory process governed by the Agence Marocaine des Médicaments et des Produits de Santé (AMMPS) under Morocco’s Ministry of Health and Social Protection. AMMPS replaced the former Direction du Médicament et de la Pharmacie (DMP) following the promulgation of Loi 10-22 by Dahir 1-23-54 on July 12, 2023. Under Loi 84-12 (the medical devices law) and its implementing Décret 2-14-607, all medical devices manufactured in or imported into Morocco must be registered with AMMPS before marketing. The process involves device classification under an EU MDD-aligned system (Class I through Class III), dossier preparation in French, submission via the PortNet electronic platform, and review by the AMMPS advisory commission. Registration results in a certificate valid for 5 years, with per-model registration required for each device variant.

Yes, CE marking is widely recognized and accepted by AMMPS as evidence of conformity for medical devices seeking registration in Morocco. Morocco’s regulatory framework is aligned with the EU Medical Devices Directive (MDD 93/42/EEC), and devices bearing valid CE marking from an EU Notified Body benefit from a streamlined review process. However, CE marking alone does not exempt manufacturers from the full AMMPS registration process. Manufacturers must still submit a complete dossier including the EC certificate, Declaration of Conformity (DoC), technical documentation, and supporting evidence. The CE marking acceptance significantly reduces the documentation burden, as AMMPS accepts EU conformity assessment results in lieu of redundant local testing for most device categories.

The Local Authorized Representative (ALR) is a mandatory requirement for all foreign manufacturers seeking to register medical devices in Morocco. Under Loi 84-12 and Décret 2-14-607, the ALR serves as the legal entity responsible for the device on Moroccan territory. The ALR must be a Moroccan-registered company with a qualified pharmacist or biomedical engineer on staff, maintain adequate warehouse and storage facilities for medical devices, have established recall and field safety corrective action procedures, and serve as the primary point of contact between the manufacturer and AMMPS. The ALR is responsible for matériovigilance reporting, handling regulatory correspondence, managing import permits, and ensuring ongoing compliance with Moroccan regulations. NexorTest assists foreign manufacturers in appointing and managing qualified ALRs throughout the registration lifecycle.

Morocco classifies medical devices using an EU MDD-aligned classification system under Loi 84-12. Devices are categorized into risk-based classes: Class I (low risk, including non-sterile bandages and tongue depressors), Class Im (low risk with measuring function), Class Is (low risk sterile), Class IIa (medium risk, including surgical instruments and hearing aids), Class IIb (medium-high risk, including ventilators and infusion pumps), and Class III (highest risk, including implantable devices and cardiovascular catheters). The classification rules follow Annex IX of the EU MDD 93/42/EEC, considering factors such as duration of contact, degree of invasiveness, active vs. non-active nature, and dependency on a source of energy. Device classification determines the registration pathway, documentation requirements, review timeline, and level of AMMPS scrutiny.

AMMPS medical device registration requires a comprehensive dossier prepared in French. Required documents include: administrative documents (application form, ALR appointment letter, manufacturer’s authorization, Free Sale Certificate from country of origin), technical documentation (device description, product specifications, manufacturing process details, materials and components list, packaging and labeling samples in French and Arabic), ISO 13485 QMS certificate, risk management file (ISO 14971), clinical evaluation report per Article 15 of Loi 84-12, CE certificate and Declaration of Conformity (for CE-marked devices), biocompatibility test reports (ISO 10993 if applicable), electrical safety reports (IEC 60601 if applicable), software validation documentation (IEC 62304 for SaMD), post-market surveillance plan, and matériovigilance procedures. All documents must be either originally in French or accompanied by certified French translations.

Medical device registration timelines in Morocco vary by device classification. Class I devices follow a simplified notification pathway taking approximately 3-4 monthsClass IIa devices undergo standard AMMPS review, typically requiring 4-6 monthsClass IIb devices require full review with clinical evaluation, generally taking 6-9 monthsClass III devices are subject to the most stringent review process, often requiring 9-12 months. Under Moroccan regulations, AMMPS has a statutory 120-day review period for standard applications, though this may be extended if queries or additional information requests are issued. The registration certificate, once granted, is valid for 5 years and must be renewed before expiration. NexorTest’s expertise in preparing complete, query-free dossiers helps minimize review cycles and achieve faster registration timelines.

Morocco requires medical device labeling to be provided in French and Arabic, the country’s two official languages. Under Loi 84-12 and Décret 2-14-607, all device labels, instructions for use (IFU), packaging, and user-facing documentation must include both French and Arabic text. Key labeling elements that must appear in both languages include: device name and intended purpose, manufacturer name and address, ALR name and address in Morocco, lot number or serial number, expiration date or use-by date, storage and handling conditions, warnings and precautions, and the CE marking symbol (if applicable). Technical documentation and the registration dossier submitted to AMMPS must be in French. NexorTest provides complete bilingual labeling and documentation services to ensure full compliance with Morocco’s language requirements.

Yes, NexorTest provides specialized IVD registration services for the Moroccan market through AMMPS. In Vitro Diagnostic devices in Morocco follow a dedicated registration pathway with additional requirements beyond standard medical devices. IVD registration involves local technical evaluation, extended timelines of up to 12 months for higher-risk IVDs, and IVD-specific documentation including analytical performance data, clinical performance evaluation, and reference material information. Our IVD registration services cover classification under Morocco’s IVD-specific categories, preparation of IVD technical dossiers in French, local performance evaluation coordination, AMMPS submission and advisory commission support, and import permit management for IVD reagents and instruments. NexorTest’s team has extensive experience navigating Morocco’s IVD regulatory landscape and can guide manufacturers from initial classification through registration certificate issuance.

Ready to Enter the Moroccan Medical Device Market?

Get a free AMMPS regulatory assessment from Morocco’s leading medical device registration consultants. Our experts will map your fastest path to market.

Global Regulatory Services

Expand Beyond Morocco with Multi-Market Access

Leverage NexorTest's global regulatory network to register your medical device in 30+ markets from a single integrated program.

Scroll to Top